NCT06377007

Brief Summary

Cataract surgery represents a common surgical intervention, encompassing the extraction of the opaque natural crystalline lens, followed by the substitution with an artificial intraocular lens (IOL). To ascertain an IOL possessing optimal power, antecedent to the surgery, preoperative evaluations are conducted through the utilization of a biometric devices. Diverse categories of these instruments are accessible, each harnessing distinct optical methodologies or mathematical algorithms to ascertain the most fitting IOL power. The principal objective of this study was to evaluate the ocular biometry and the predictive precision outcome of a biometer that uses standard keratometry to the prediction accuracy of another biometer that uses Total Keratometry.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 26, 2024

Status Verified

April 1, 2024

Enrollment Period

1.6 years

First QC Date

January 30, 2024

Last Update Submit

April 24, 2024

Conditions

Keywords

BiometrySS-OCTIOLMaster700Argos

Outcome Measures

Primary Outcomes (1)

  • Mean absolute prediction error

    Mean absolute prediction error determining by the absolute disparity between the predicted spherical equivalent refraction derived from preoperative planning and the actual measured spherical equivalent refraction (manifest) from both devices (IOLMaster 700 and Argos)

    4 weeks

Secondary Outcomes (1)

  • Proportion of eyes with an absolute prediction error equal to or less than 0.25

    4 weeks

Study Arms (2)

IOLMaster 700

ACTIVE COMPARATOR

IOLMaster 700 represents the gold standard for measuring ocular biometry before cataract surgery, employing a single refractive index.

Device: IOLMaster 700 (Carl Zeiss Meditec AG)

ARGOS

EXPERIMENTAL

ARGOS is a new device used to measure ocular biometry. It employs distinct refractive indices for different eye components such as the cornea, lens, and vitreous.

Device: Argos (Alcon Laboratories, Inc.)

Interventions

Subjects will undergo measurements with the IOLMaster 700 device.

IOLMaster 700

Subjects will undergo measurements with the Argos device.

ARGOS

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.

You may not qualify if:

  • Central corneal thickness less than 490 mm or greater than 600 mm
  • Contact lens use within 2 months of cataract surgery
  • Severe dry eye
  • Corneal or retinal disease affecting visual outcome
  • Corneal astigmatism greater than 1.00 D
  • Prior corneal refractive surgery
  • Dense cataract that does not allow measurements to be taken with an optical biometrics system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Walailak University

Nakhon Si Thammarat, 80160, Thailand

RECRUITING

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Central Study Contacts

Jakkrit Juhong, MD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

April 22, 2024

Study Start

January 1, 2024

Primary Completion

July 30, 2025

Study Completion

December 30, 2025

Last Updated

April 26, 2024

Record last verified: 2024-04

Locations